BioNTech SE (BNTX) Total Non-Current Liabilities (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Total Non-Current Liabilities data on file, last reported at $724.2 million in Q4 2025.

• For the quarter ending Q4 2025, Total Non-Current Liabilities rose 13.82% year-over-year to $724.2 million; the trailing twelve-month figure through Dec 2025 stood at $724.2 million (up 13.82% YoY), and the FY2025 full-year result was $702.9 million, up 10.47% from the prior year.
• Total Non-Current Liabilities retreated to $724.2 million in Q4 2025, from $749.7 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $1.5 billion in Q2 2025 to a low of $278.4 million in Q4 2022.
• A 5-year average of $639.9 million and a median of $620.8 million in 2021 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities surged 237.3% in 2021 and sank 53.47% in 2022, its largest moves.
• Tracing BNTX's Total Non-Current Liabilities over 5 years: stood at $521.1 million in 2021, then tumbled by 46.57% to $278.4 million in 2022, then jumped by 166.6% to $742.3 million in 2023, then decreased by 14.29% to $636.2 million in 2024, then climbed by 13.82% to $724.2 million in 2025.
• Business Quant data shows BNTX's Total Non-Current Liabilities at $724.2 million in Q4 2025, $749.7 million in Q3 2025, and $1.5 billion in Q2 2025.